{"nctId":"NCT00143403","briefTitle":"Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal Cancer","startDateStruct":{"date":"2001-12"},"conditions":["Colorectal Neoplasms","Liver Neoplasms"],"count":321,"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Drug: Irinotecan + 5 FU + folinic acid"]},{"label":"2","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Folinic Acid + 5 FU"]}],"interventions":[{"name":"Irinotecan + 5 FU + folinic acid","otherNames":[]},{"name":"Folinic Acid + 5 FU","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Histologically proven adenocarcinoma of the colon or rectum with complete resection of primary tumour.\n* Complete surgical resection (R0) of the liver metastasis(es) within a minimum of 3 weeks, and a maximum of 8 weeks prior to the first study treatment infusion.\n* Exclusively hepatic metastasis (es) : absence of bone, lung and brain metastases.\n\nExclusion Criteria:\n\n* Prior hepatic radiation or resection.\n* Prior radiofrequency ablation or cryoablation Incomplete surgical resection of liver metastasis (es).\n* Prior chemotherapy for metastatic disease.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"75 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Disease Free Survival (DFS)","description":"time interval between the date of randomization and the earliest date of local, regional or distant relapse, or death due to cancer.","paramType":"MEDIAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"21.6","spread":null},{"groupId":"OG001","value":"24.7","spread":null}]}]}]},{"type":"SECONDARY","title":"Overall Survival Rates","description":"Probability of being alive was calculated in a yearly increment.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.961","spread":null},{"groupId":"OG001","value":"0.973","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.845","spread":null},{"groupId":"OG001","value":"0.881","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.716","spread":null},{"groupId":"OG001","value":"0.727","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":15,"n":152},"commonTop":["Nausea","Diarrhea, NOS","Asthenia","Vomiting, NOS","Alopecia"]}}}